DIABETIC KIDNEY DISEASE
Clinical trials for DIABETIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new DIABETIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for DIABETIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shield kidneys in diabetic veterans
Disease control Not yet recruitingThis study looks at whether the drugs finerenone and empagliflozin, alone or together, can protect kidney cells in African American veterans with diabetic kidney disease. Researchers will measure markers of kidney health in urine and blood. The goal is to find better ways to slow…
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE4 • Sponsor: Washington D.C. Veterans Affairs Medical Center • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
New study aims to find safer heart failure treatment for kidney patients
Disease control Not yet recruitingThis study tests whether a newer drug, finerenone, is safer than an older drug, spironolactone, for people with heart failure and diabetic kidney disease who are at high risk for high potassium levels. About 60 participants will receive either finerenone daily or spironolactone e…
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE4 • Sponsor: Hospital de Messejana Dr. Carlos Alberto Studart Gomes • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Gut bacteria may hold key to slowing kidney disease in diabetes
Knowledge-focused Not yet recruitingThis study looks at how gut bacteria and substances in the blood affect blood sugar ups and downs in people with diabetic kidney disease. Researchers will follow 270 adults to see if these factors can predict kidney disease getting worse. The goal is to find new ways to identify …
Matched conditions: DIABETIC KIDNEY DISEASE
Sponsor: Eighth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated May 17, 2026 07:06 UTC
-
New drug MTX-439 enters first human safety tests
Knowledge-focused Not yet recruitingThis early-stage study tests the safety and how the body handles a new drug called MTX-439. It involves 88 healthy adults and people with diabetic kidney disease. The main goal is to check for side effects and measure drug levels in the blood, not to treat the disease.
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE1 • Sponsor: Mediar Therapeutics • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC